Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II

Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II

Aim. To assess the efficacy and safety of Vamloset (amlodipine/valsartan 5/80, 5/160, 10/160 mg) and Co-Vamloset (amlodipine/valsartan/hydrochlorothiazide 10/160/12.5, 10/160/25 mg) in achieving the target levels of blood pressure (BP) in patients with stage 23 arterial hypertension (AH). The articl...

Full description

Saved in:
Bibliographic Details
Main Authors: Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galyavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Format: article
Language:RU
Published: IP Morozov P.V. 2021
Subjects:
victory ii
russian clinical study
adherence
arterial hypertension
fixed dose combinations
single pill combinations
valsartan
amlodipine
hydrochlorothiazide
vamloset®
co-vamloset
Diseases of the circulatory (Cardiovascular) system
RC666-701
Online Access:https://doaj.org/article/60c64f07123347219ac33339c22c4a57
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/60c64f07123347219ac33339c22c4a57

Similar Items